Situating Standards in Practices: Multi Drug-Resistant Tuberculosis Treatment in India

被引:4
|
作者
Engel, Nora [1 ]
Zeiss, Ragna [2 ]
机构
[1] Maastricht Univ, Dept Hlth Eth & Soc, CAPHRI, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Dept Technol & Soc Studies, Fac Arts & Social Sci, NL-6200 MD Maastricht, Netherlands
关键词
standardization; local adaptation; control; healthcare innovation; tuberculosis; India; UNIVERSALITY; TB;
D O I
10.1080/09505431.2013.837875
中图分类号
G [文化、科学、教育、体育]; C [社会科学总论];
学科分类号
03 ; 0303 ; 04 ;
摘要
Public health care needs to cope with a basic dilemma between providing standardized care within public programmes across entire and at times resource-constrained countries and adapting this care locally when responding to individual needs. This tension between standardization and local adaptation becomes particularly obvious for the prolonged and complicated treatment of multidrug-resistant tuberculosis (MDR-TB). Situated standardization, as introduced by Zuiderent-Jerak [2007a, 2007b] offers a way out of this dilemma. It helps to focus on how standards need to be situated in practice rather than viewing standardization and local adaptation as mutually exclusive practices. How do actors relate standardization and individual care in their practices of treating MDR-TB? Results from qualitative fieldwork at the first MDR-TB treatment sites of the Indian TB programme show that actors situate standards in a particular way. They assess the role of guidelines in a particular situation and on that basis recognize the core recommendations of guidelines or go beyond the guidelines. This allows actors to negotiate how standards should be situated and reconciles the dilemma between local adaptation and standardization. Having guidelines internalized, as is common for Indian TB control, bears both promises and pitfalls for engaging in standardization processes in a situated manner. The results contribute to science and technology study scholarship on guideline development. They highlight how actors coordinate the situating of standards and how this depends upon cultures of control. This illustrates the potential of qualitative studies on local adaptation for guideline developers by revealing existing practices of relating and negotiating local adaptation and standardization.
引用
收藏
页码:201 / 225
页数:25
相关论文
共 50 条
  • [21] Linezolid in the treatment of extensively drug-resistant tuberculosis
    L. Zhang
    Y. Pang
    X. Yu
    Y. Wang
    M. Gao
    H. Huang
    Y. Zhao
    Infection, 2014, 42 : 705 - 711
  • [22] Drug-resistant tuberculosis: emerging treatment options
    Adhvaryu, Meghna
    Vakharia, Bhasker
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 51 - 67
  • [23] Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis
    van Rijn, Sander P.
    Zuur, Marlanka A.
    Anthony, Richard
    Wilffert, Bob
    van Altena, Richard
    Akkerman, Onno W.
    de Lange, Wiel C. M.
    van der Werf, Tjip S.
    Kosterink, Jos G. W.
    Alffenaar, Jan-Willem C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
  • [24] Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research
    Mistry, Nerges
    Tolani, Monica
    Osrin, David
    OPERATIONS RESEARCH FOR HEALTH CARE, 2012, 1 (2-3) : 45 - 53
  • [25] Drug-resistant and extensively drug-resistant tuberculosis in southern Africa
    Grobusch, Martin Peter
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (03) : 180 - 185
  • [26] Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Centre, Chennai, India
    Thomas, A.
    Joseph, P.
    Nair, D.
    Rao, D. V. B.
    Rekha, V. V. B.
    Selvakumar, N.
    Jaggarajamma, K.
    Balambal, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (10) : 1323 - 1325
  • [27] Advances in the Treatment Options Towards Drug-Resistant Tuberculosis
    Bule, Mohammed Hussen
    Maqbool, Faheem
    Ahmed, Ishtiaq
    Dhama, Kuldeep
    Iqbal, Hafiz Muhammad Nasir
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2017, 13 (07) : 746 - 761
  • [28] New agents for the treatment of drug-resistant Mycobacterium tuberculosis
    Hoagland, Daniel T.
    Liu, Jiuyu
    Lee, Robin B.
    Lee, Richard E.
    ADVANCED DRUG DELIVERY REVIEWS, 2016, 102 : 55 - 72
  • [29] Undernutrition and Treatment Success in Drug-Resistant Tuberculosis in Uganda
    Baluku, Joseph Baruch
    Namiiro, Sharon
    Nabwana, Martin
    Muttamba, Winters
    Kirenga, Bruce
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 3673 - 3681
  • [30] Gaps in the Diagnosis and Treatment of Drug-resistant Tuberculosis in Mexico
    Laniado-Laborin, Rafael
    Castro-Mazon, Gerardo
    Salcido-Gastelum, Jorge
    Saavedra-Herrera, Nallely
    Magana-Ocana, Julio
    Luna-Lopez, Fatima Leticia
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2024, 20 (01) : 20 - 23